Publications
389
Citations
8,138
Est. group size
~27
Recurring co-author estimate
Active years
22
Publishing since 2005
Maged M. Costantine's research focuses on maternal-fetal medicine, covering topics such as preeclampsia and other hypertensive disorders of pregnancy, gestational diabetes, preterm birth, medication use during pregnancy (pharmacokinetics), and pregnancy outcomes related to infections like SARS-CoV-2 and cytomegalovirus. Much of the work involves large multicenter cohort studies examining how pregnancy complications affect both maternal and infant health outcomes, including long-term cardiovascular risk and social determinants of health. This research area would suit students interested in clinical and translational obstetric research, particularly studies involving large patient cohorts and pregnancy-related drug safety.
Publication output rose sharply from 2017 to a peak in 2021, then gradually declined but has remained steady at a relatively high level (around 20-35 papers/year) through 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Childhood Pulmonary Outcomes After Late Preterm Antenatal Corticosteroids
Obstetrics and Gynecology · 2026
- Maternal Cytomegalovirus Serology Results by Geographic Region in a Large Multicenter US Study
The Journal of Infectious Diseases · 2026
- The Association of the Social Vulnerability Index with Acuity of Presentation to Obstetric Triage
American Journal of Perinatology · 2026
- Social Determinants of Health and Risk for Long COVID in the U.S. RECOVER-Adult Cohort
Annals of Internal Medicine · 2025
- Hypertensive disorders of pregnancy and gestational diabetes mellitus and predicted risk of maternal cardiovascular disease 10–14 years after delivery: A prospective cohort
Diabetic Medicine · 2025
- Diagnosis of hypertensive disorders in pregnancy
American Journal of Obstetrics & Gynecology MFM · 2025
- Placental alkaline phosphatase (PLAP): Is it exclusively placental?
Placenta · 2025
- Serum soluble-fms-like tyrosine kinase 1-to-placental growth factor ratio on Elecsys immunoassay platform predicts preeclampsia with severe features in hospitalized women with hypertensive disorders of pregnancy
American Journal of Obstetrics and Gynecology · 2025
- Changes in <i>S</i>‐Citalopram Plasma Concentrations Across Pregnancy and Postpartum
Clinical Pharmacology & Therapeutics · 2025
- Association between Induction Start Time and Labor Duration in Nulliparous Women Undergoing Elective Induction of Labor
American Journal of Perinatology · 2025
- Development of a Risk-Scoring System for Prediction of Blood Transfusion During Hospitalization for Delivery
O&G Open · 2025
- Daily Versus BID Nifedipine GITS in Severe Preeclampsia: Randomized Controlled Trial
Hypertension · 2025
- Characteristics and outcomes associated with multiple triage visits among patients with suspected preterm labor or preterm premature rupture of membranes
AJOG Global Reports · 2025
- Racial and Ethnic Differences in Utilization of Labor Management Strategies Intended to Reduce Cesarean Delivery Rates
UNC Libraries · 2025
- Pharmacokinetic profiles of sertraline in pregnancy as a predictor of postpartum depressive symptoms
British Journal of Clinical Pharmacology · 2025
- American Journal of Obstetrics and Gynecology×71
- Obstetrics and Gynecology×29
- American Journal of Perinatology×28
- American Journal of Obstetrics & Gynecology MFM×11
- UNC Libraries×11
- Samuel Parry
Medicine · The Ohio State University
- Edward K. Chien
Medicine · The Ohio State University
- George R. Saade
Medicine · The Ohio State University
- Hyagriv N. Simhan
Medicine · The Ohio State University
- Mark A. Klebanoff
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile